Mackenzie Financial Corp Trinity Biotech PLC Transaction History

Mackenzie Financial Corp

  • $66.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$2.77 - $4.18 $53,704 - $81,041
-19,388 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$3.26 - $6.64 $5,581 - $11,367
-1,712 Reduced 8.11%
19,388 $73,000
Q4 2020

Feb 10, 2021
BUY
$1.95 - $4.77 $41,145 - $100,646
21,100 New
21,100 $80,000

Others Institutions Holding TRIB

# of Institutions
1
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About TRINITY BIOTECH PLC

TRIB Quotes by TradingView
  • Ticker TRIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 38,107,600
  • Market Cap $32.4M
  • Description
  • Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...
More about TRIB
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email